Health In Tech terminates chief technology officer without cause

Published 26/11/2025, 23:12
Health In Tech terminates chief technology officer without cause

Health In Tech, Inc. (NASDAQ:HIT) announced the termination of Imran Yousuf from his role as chief technology officer, effective Tuesday. According to a statement in a press release and an SEC filing, the termination was without cause and was not the result of any disagreement related to the company’s operations, policies, or practices.

The company, based in Stuart, Florida, disclosed the leadership change under Item 5.02 of its Form 8-K filed with the Securities and Exchange Commission. No further details regarding the transition or plans for the position were provided in the filing.

Health In Tech’s Class A common stock trades on the Nasdaq Capital Market under the symbol HIT. The company is classified under insurance agents, brokers, and services.

The information in this article is based on a statement in a press release and the company’s SEC filing.

In other recent news, Health In Tech reported significant financial results for the third quarter of 2025. The company experienced a remarkable 90% increase in revenue compared to the previous year, reaching $8.5 million. Earnings per share met analysts’ expectations at $0.01, indicating steady financial performance. These results were discussed during a conference call, with the transcript now available for investors. The call also highlighted strategic initiatives that may contribute to future growth. Additionally, despite no earnings surprise, the market’s reaction was positive, reflecting investor confidence. These developments are part of Health In Tech’s ongoing efforts to enhance its market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.